RiskofNeverTakingHRT/Data: Difference between revisions
Risk of Never Taking HRT for Menopause / Data |
m Text replacement - "datatable2" to "riskdata" |
||
| Line 2: | Line 2: | ||
== Fracture Risk Data == | == Fracture Risk Data == | ||
< | <riskdata table="FractureRiskTable" columns="label|withHRT|withoutHRT"> | ||
<head> | <head> | ||
! Scenario (for dropdown) | ! Scenario (for dropdown) | ||
| Line 10: | Line 10: | ||
7.1 years – estrogen‑only HRT | 92–113 | 141 | 7.1 years – estrogen‑only HRT | 92–113 | 141 | ||
5.6 years – combined HRT | 79–96 | 111 | 5.6 years – combined HRT | 79–96 | 111 | ||
</ | </riskdata> | ||
*Explanation:* | *Explanation:* | ||
| Line 23: | Line 23: | ||
== Cardiovascular, Stroke, and VTE Risk Data == | == Cardiovascular, Stroke, and VTE Risk Data == | ||
< | <riskdata table="CardiovascularRiskTable" columns="condition|withHRT|withoutHRT"> | ||
<head> | <head> | ||
! Condition (for dropdown) | ! Condition (for dropdown) | ||
| Line 32: | Line 32: | ||
Stroke | 44 | 32 | Stroke | 44 | 32 | ||
Venous thromboembolism (VTE) | 34 | 16 | Venous thromboembolism (VTE) | 34 | 16 | ||
</ | </riskdata> | ||
*Explanation:* | *Explanation:* | ||
| Line 57: | Line 57: | ||
== Cancer Risk Data == | == Cancer Risk Data == | ||
< | <riskdata table="CancerRiskTable" columns="cancerType|withHRT|withoutHRT"> | ||
<head> | <head> | ||
! Cancer Type (for dropdown) | ! Cancer Type (for dropdown) | ||
| Line 66: | Line 66: | ||
Ovarian Cancer | ~1 per 1,000 | baseline varies | Ovarian Cancer | ~1 per 1,000 | baseline varies | ||
Endometrial Cancer (combined HRT) | reduced/neutral | baseline varies | Endometrial Cancer (combined HRT) | reduced/neutral | baseline varies | ||
</ | </riskdata> | ||
*Explanation:* | *Explanation:* | ||
| Line 85: | Line 85: | ||
== Dementia Risk Data == | == Dementia Risk Data == | ||
< | <riskdata table="DementiaRiskTable" columns="scenario|withHRT|withoutHRT"> | ||
<head> | <head> | ||
! Scenario (for dropdown) | ! Scenario (for dropdown) | ||
| Line 92: | Line 92: | ||
</head> | </head> | ||
Women ≥65, combined HRT | 11 | 9 | Women ≥65, combined HRT | 11 | 9 | ||
</ | </riskdata> | ||
*Explanation:* | *Explanation:* | ||
Latest revision as of 17:34, 12 September 2025
Data for RiskOfNeverTakingHRTForMenopause
Fracture Risk Data
| Scenario (for dropdown) | Fractures with HRT (per 1000) | Fractures without HRT (per 1000) |
|---|---|---|
|
7.1 years – estrogen‑only HRT |
92–113 |
141 |
|
5.6 years – combined HRT |
79–96 |
111 |
- Explanation:*
Women on HRT had fewer fractures than those not taking it—for both estrogen-only and combined regimens. - Source: [PubMed – WHI WHR Study](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:FractureRiskModel
Content:
label = label
withHRT = withHRT
withoutHRT = withoutHRT
Cardiovascular, Stroke, and VTE Risk Data
| Condition (for dropdown) | Incidence with HRT (per 10,000) | Incidence without HRT (per 10,000) |
|---|---|---|
|
Coronary heart disease |
157 |
132 |
|
Stroke |
44 |
32 |
|
Venous thromboembolism (VTE) |
34 |
16 |
- Explanation:*
Combined HRT is associated with slightly higher incidence of CHD, stroke, and VTE. - Source: [CMAJ WHI Summary](https://www.cmaj.ca/content/170/10/1535?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:CHDRiskModel
Content:
condition = 'Coronary heart disease'
withHRT = withHRT
withoutHRT = withoutHRT
RiskModel: RiskofNeverTakingHRT/Data:StrokeRiskModel
Content:
condition = 'Stroke'
withHRT = withHRT
withoutHRT = withoutHRT
RiskModel: RiskofNeverTakingHRT/Data:VTERiskModel
Content:
condition = 'Venous thromboembolism (VTE)'
withHRT = withHRT
withoutHRT = withoutHRT
Cancer Risk Data
| Cancer Type (for dropdown) | Incidence with HRT (per women-years) | Baseline without HRT |
|---|---|---|
|
Breast Cancer (combined HRT) |
+9 to +36 per 10,000 |
baseline varies |
|
Ovarian Cancer |
~1 per 1,000 |
baseline varies |
|
Endometrial Cancer (combined HRT) |
reduced/neutral |
baseline varies |
- Explanation:*
Combined HRT may increase breast and ovarian cancer risk, but appears neutral or protective for endometrial cancer. - Sources:
- [Menopause.org.au Breast Cancer](https://www.menopause.org.au/members/ims-menopause-live/use-of-hormone-replacement-therapy-hrt-and-risk-of-breast-cancer?utm_source=chatgpt.com) - [SAGE Journal Analysis](https://journals.sagepub.com/doi/10.1177/2053369120957514?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:BreastCancerRiskModel
Content:
cancerType = 'Breast Cancer (combined HRT)'
withHRT = withHRT
RiskModel: RiskofNeverTakingHRT/Data:OvarianCancerRiskModel
Content:
cancerType = 'Ovarian Cancer'
withHRT = withHRT
Dementia Risk Data
| Scenario (for dropdown) | Dementia incidence with HRT (per 1000) | Dementia incidence without HRT (per 1000) |
|---|---|---|
|
Women ≥65, combined HRT |
11 |
9 |
- Explanation:*
In women aged 65+, combined HRT is tied to slightly higher dementia risk. - Source: [WHI Memory Study – PubMed](https://pubmed.ncbi.nlm.nih.gov/28093732/?utm_source=chatgpt.com)
RiskModel: RiskofNeverTakingHRT/Data:DementiaRiskModel
Content:
scenario = 'Women ≥65, combined HRT'
withHRT = withHRT
withoutHRT = withoutHRT
Uncertainty Note
These figures represent population averages and may not apply to every individual due to variables like geography, age at menopause, HRT type, and personal health.
Generated by an AI assistant.